Harima Chemicals Group, Inc. (TYO:4410)
Japan · Delayed Price · Currency is JPY 1,371.00
-60.00 (-4.19%)
Nov 6, 2026, 3:30 PM JST
Harima Chemicals Group Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 112,922 | 103,763 | 101,006 | 92,330 | 94,510 | 76,093 | |
Revenue Growth | 9.51% | 2.73% | 9.40% | -2.31% | 24.20% | 21.07% |
Cost of Revenue | 87,449 | 80,823 | 79,211 | 74,408 | 75,300 | 58,116 |
Gross Profit | 25,473 | 22,940 | 21,795 | 17,922 | 19,210 | 17,977 |
Selling, General & Admin | 16,744 | 16,207 | 16,374 | 14,866 | 14,303 | 11,839 |
Research & Development | 2,868 | 2,868 | 2,782 | 2,707 | 2,731 | 2,536 |
Operating Expenses | 20,193 | 19,656 | 19,711 | 18,133 | 17,504 | 14,726 |
Operating Income | 5,280 | 3,284 | 2,084 | -211 | 1,706 | 3,251 |
Interest Expense | -1,156 | -1,099 | -987 | -579 | -424 | -272 |
Interest & Investment Income | 99 | 142 | 256 | 307 | 193 | 124 |
Earnings From Equity Investments | 806 | 496 | -306 | 190 | 1,042 | 292 |
Currency Exchange Gain (Loss) | -106 | -158 | 71 | -471 | -207 | 56 |
Other Non Operating Income (Expenses) | 361 | 445 | 245 | 510 | 238 | 35 |
EBT Excluding Unusual Items | 5,284 | 3,110 | 1,363 | -254 | 2,548 | 3,486 |
Gain (Loss) on Sale of Investments | 383 | 184 | 858 | 193 | 379 | - |
Gain (Loss) on Sale of Assets | 207 | 207 | -34 | -22 | -8 | -53 |
Asset Writedown | -300 | -300 | -358 | -125 | -105 | -439 |
Other Unusual Items | -50 | -27 | -12 | -44 | -493 | - |
Pretax Income | 5,524 | 3,174 | 1,817 | -252 | 2,321 | 2,994 |
Income Tax Expense | 1,282 | 831 | 1,039 | 639 | 1,038 | 882 |
Earnings From Continuing Operations | 4,242 | 2,343 | 778 | -891 | 1,283 | 2,112 |
Minority Interest in Earnings | -17 | 2 | -15 | -270 | -398 | -366 |
Net Income | 4,225 | 2,345 | 763 | -1,161 | 885 | 1,746 |
Net Income to Common | 4,225 | 2,345 | 763 | -1,161 | 885 | 1,746 |
Net Income Growth | 321.66% | 207.34% | - | - | -49.31% | 60.04% |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 25 | 25 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 25 | 25 |
Shares Change | 0.19% | 0.17% | 0.13% | -2.20% | -1.53% | 0.12% |
EPS (Basic) | 173.73 | 96.52 | 31.46 | -47.93 | 35.73 | 69.41 |
EPS (Diluted) | 173.73 | 96.52 | 31.46 | -47.93 | 35.73 | 69.41 |
EPS Growth | 320.85% | 206.82% | - | - | -48.52% | 59.85% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 6,252 | 4,279 | 684 | -2,943 | -3,989 | 244 |
Free Cash Flow Per Share | 257.07 | 176.12 | 28.20 | -121.50 | -161.05 | 9.70 |
Dividend Per Share | 44.000 | 42.000 | 42.000 | 42.000 | 38.000 | 38.000 |
Dividend Growth | 4.76% | 0% | 0% | 10.53% | 0% | - |
Gross Margin | 22.56% | 22.11% | 21.58% | 19.41% | 20.33% | 23.63% |
Operating Margin | 4.68% | 3.16% | 2.06% | -0.23% | 1.80% | 4.27% |
Profit Margin | 3.74% | 2.26% | 0.76% | -1.26% | 0.94% | 2.30% |
Free Cash Flow Margin | 5.54% | 4.12% | 0.68% | -3.19% | -4.22% | 0.32% |
EBITDA | 8,437 | 6,286 | 4,911 | 2,518 | 4,175 | 5,426 |
EBITDA Margin | 7.47% | 6.06% | 4.86% | 2.73% | 4.42% | 7.13% |
D&A For EBITDA | 3,157 | 3,002 | 2,827 | 2,729 | 2,469 | 2,175 |
EBIT | 5,280 | 3,284 | 2,084 | -211 | 1,706 | 3,251 |
EBIT Margin | 4.68% | 3.16% | 2.06% | -0.23% | 1.80% | 4.27% |
Effective Tax Rate | 23.21% | 26.18% | 57.18% | - | 44.72% | 29.46% |